Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain

  1. Calvo Aller, E.
  2. Maroto, P.
  3. Kreif, N.
  4. González Larriba, J.L.
  5. López-Brea, M.
  6. Castellano, D.
  7. Martí, B.
  8. Díaz Cerezo, S.
Journal:
Clinical and Translational Oncology

ISSN: 1699-048X 1699-3055

Year of publication: 2011

Volume: 13

Issue: 12

Pages: 869-877

Type: Article

DOI: 10.1007/S12094-011-0748-0 GOOGLE SCHOLAR